Severe (level 3) hypoglycaemia occurrence in a real-world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States).

ABSTRACT:

Aims

Among adults with insulin- and/or secretagogue-treated diabetes in the United States, very little is known about the real-world descriptive epidemiology of iatrogenic severe (level 3) hypoglycaemia. Addressing this gap, we collected primary, longitudinal data to quantify the absolute frequency of events as well as incidence rates and proportions.

Materials and methods

iNPHORM is a US-wide, 12-month ambidirectional panel survey (2020-2021). Adults with type 1 diabetes mellitus (T1DM) or insulin- and/or secretagogue-treated type 2 diabetes mellitus (T2DM) were recruited from a probability-based internet panel. Participants completing ≥1 follow-up questionnaire(s) were analysed.

Results

Among 978 respondents [T1DM 17%; mean age 51 (SD 14.3) years; male: 49.6%], 63%

SUBMITTER: Ratzki-Leewing A 

PROVIDER: S-EPMC10958739 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature